MedTrace Logo

Clinical Investigation of Buttermere (LENS 271) Soft Contact Lenses

NCT06609018 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 73

Last updated 2026-02-24

No results posted yet for this study

Summary

The purpose of the study is to compare clinical performance between two soft contact lenses.

Conditions

  • Myopia

Interventions

DEVICE

Test Lenses (stenfilcon A)

Daily disposable, soft contact lenses worn for one week

DEVICE

Control Lenses (omafilcon A)

Daily disposable, soft contact lenses worn for one week

Sponsors & Collaborators

  • CooperVision, Inc.

    lead INDUSTRY

Principal Investigators

  • Michel Guillon, PhD · Ocular Technology Group- International

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
DOUBLE
Model
CROSSOVER

Eligibility

Min Age
8 Years
Max Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2024-08-01
Primary Completion
2025-03-05
Completion
2025-03-05
FDA Device
Yes

Countries

  • United Kingdom

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06609018 on ClinicalTrials.gov